Company

Companies of New York

Moderna
Subscribe to the company
Moderna

Moderna

Healthcare

Connections 39

Subscribe To favorites

Description

Moderna is an American biotechnology company based in Cambridge, Massachusetts that focus on drug discovery, drug development, and vaccine technologies based exclusively on messenger RNA (mRNA).

Synopsis

The Moderna technology platform is to insert synthetic mRNA into living cells that would reprogram the cells to develop immune responses, rather than being created externally and injected as with conventional medicines. It is a novel technique abandoned by several large pharmaceutical and biotechnology companies that were unable to overcome the side effects of inserting RNA into cells. As of May 2020, no mRNA drug has been approved for human use.

Moderna has conducted mostly unsuccessful trials in traditional high-margin chronic therapeutic areas with AstraZeneca, and in orphan diseases with Alexion Pharmaceuticals. In 2014, Moderna moved to focus on lower-margin vaccines, given that an mRNA vaccine – efficacy issues aside – will always stimulate a level of antibody development in subjects. The strategic change led industry experts, and Moderna employees, to question the financial viability of the company. In the opinion of some former Moderna employees, the safe dose was too weak and "repeat injections of a dose strong enough to be effective had troubling effects on the liver in animal studies."

In December 2018, Moderna became the largest biotech initial public offering (IPO) in history, raising US$600 million for 8% of its shares, implying an overall valuation of $7.5 billion, and with cumulative losses of $1.5 billion and equity raised of $3.2 billion, since inception. As of May 2020, Moderna was valued at $30 billion, but none of its mRNA molecules had reached large clinical trials, and several had failed due to side-effects.

In July 2020, Moderna announced in a preliminary report that its Operation Warp Speed candidate had led to production of neutralizing antibodies in healthy adults in Phase 1 clinical testing. "At the 100-microgram dose, the one Moderna is advancing into larger trials, all 15 patients experienced side effects, including fatigue, chills, headache, muscle pain, and pain at the site of injection." The troublesome higher doses were discarded in July from future studies.

Website

http://modernatx.com

Rating GlobalNY.biz

Press Releases View all

Mentions in the news View all

Company Persons View all

Quotes

All

Savannah Guthrie Returns to ‘Today’ After Four-Day Absence

MELVIN Craig
MELVIN Craig

So glad that Savannah’s back in Studio 1A

Teen Wolf Star Dylan Sprayberry Reveals Scientology Journey After Substance Abuse Battle

SPRAYBERRY Dylan
SPRAYBERRY Dylan

I am a Scientologist. I’ve been a Scientologist for three years now. It’s been an epic experience for me

Conor McGregor Speaks Out After 69-Second UFC 329 Loss to Max Holloway

MCGREGOR Conor
MCGREGOR Conor

I will overcome this. I will not be deterred

Jimmy Kimmel Replacement Tiffany Haddish Vows to Keep Making Trump ‘Mad’ With One Move

HADDISH Tiffany
HADDISH Tiffany

I had the best time this week. I made some new friends. I told some jokes that pissed off the White House. And now I can go back to making the president mad just by being a successful Black woman

Montel Williams Makes Rare Comment About Ex-Girlfriend Kamala Harris

WILLIAMS Montel
WILLIAMS Montel

I’m one of those guys that I don’t kiss and tell